The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)
Clinical trial NCT01668004 · COMPLETED
Trial details
- NCT number
- NCT01668004
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-03
- Primary completion
- 2015-04-30
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.